Mele Donato, Luisi Giovanni Andrea, Pestelli Gabriele, Smarrazzo Vittorio, Trevisan Filippo, Savini Carlo, Ferrari Roberto
Centro Cardiologico Universitario e LTTA Centre, Università degli Studi, Ferrara.
U.O. Cardiochirurgia, Azienda Ospedaliero-Universitaria S. Orsola, Bologna.
G Ital Cardiol (Rome). 2019 Feb;20(2):97-108. doi: 10.1714/3093.30857.
The presence of secondary mitral regurgitation is an unfavorable prognostic factor in patients with chronic ischemic heart disease. This type of regurgitation can be treated with medical therapy, cardiac resynchronization therapy, surgically or percutaneously but each strategy has controversial aspects. The purpose of this review is to discuss the most debated issues relative to the various modalities available to treat ischemic secondary mitral regurgitation, highlighting also future perspectives.
继发性二尖瓣反流的存在是慢性缺血性心脏病患者的一个不良预后因素。这种类型的反流可以通过药物治疗、心脏再同步治疗、手术或经皮治疗，但每种策略都存在争议。本综述的目的是讨论与治疗缺血性继发性二尖瓣反流的各种可用方式相关的最具争议的问题，同时也强调未来的前景。
